These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29184393)

  • 1. Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study.
    Novick D; Montgomery W; Vorstenbosch E; Moneta MV; Dueñas H; Haro JM
    Patient Prefer Adherence; 2017; 11():1859-1868. PubMed ID: 29184393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study.
    Novick D; Hong J; Montgomery W; Dueñas H; Gado M; Haro JM
    Neuropsychiatr Dis Treat; 2015; 11():197-205. PubMed ID: 25653529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
    Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
    J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pain and remission in the functioning of patients with depression in Mainland China, Taiwan, and Hong Kong.
    Novick D; Shi Q; Yue L; Moneta MV; Siddi S; Haro JM
    Asia Pac Psychiatry; 2018 Jun; 10(2):e12295. PubMed ID: 28960863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study.
    Harada E; Satoi Y; Kuga A; Tokuoka H; Kikuchi T; Watanabe K; Alev L; Mimura M
    Neuropsychiatr Dis Treat; 2017; 13():2437-2445. PubMed ID: 29033569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning.
    Trivedi MH; Corey-Lisle PK; Guo Z; Lennox RD; Pikalov A; Kim E
    Int Clin Psychopharmacol; 2009 May; 24(3):133-8. PubMed ID: 19318972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
    Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
    Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension.
    Goldberg JF; Ng-Mak D; Siu C; Chuang CC; Rajagopalan K; Loebel A
    CNS Spectr; 2017 Apr; 22(2):220-227. PubMed ID: 28264739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study.
    Montoya A; Lebrec J; Keane KM; Fregenal I; Ciudad A; Moríñigo Á; Agüera-Ortiz L; Romera I; Gilaberte I; Zimmerman M
    BMC Psychiatry; 2016 Oct; 16(1):352. PubMed ID: 27760534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies.
    Spellmann I; Schennach R; Seemüller F; Meyer S; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Bauer M; Adli M; Zeiler J; Bender W; Kronmüller KT; Ising M; Brieger P; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):303-313. PubMed ID: 27785605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course of major depressive disorder from childhood to young adulthood: Recovery and recurrence in a longitudinal observational study.
    Kovacs M; Obrosky S; George C
    J Affect Disord; 2016 Oct; 203():374-381. PubMed ID: 27347807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder.
    van der Voort TY; Seldenrijk A; van Meijel B; Goossens PJ; Beekman AT; Penninx BW; Kupka RW
    J Clin Psychiatry; 2015 Jun; 76(6):e809-14. PubMed ID: 26132690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of remission status on work functioning in employed patients treated for major depressive disorder.
    Sarfati D; Stewart K; Woo C; Parikh SV; Yatham LN; Lam RW
    Ann Clin Psychiatry; 2017 Feb; 29(1):11-16. PubMed ID: 27901522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
    Cohen RM; Greenberg JM; IsHak WW
    JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.
    Judd LL; Akiskal HS; Maser JD; Zeller PJ; Endicott J; Coryell W; Paulus MP; Kunovac JL; Leon AC; Mueller TI; Rice JA; Keller MB
    Arch Gen Psychiatry; 1998 Aug; 55(8):694-700. PubMed ID: 9707379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2004 Jun; 65(6):810-9. PubMed ID: 15291658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.